Tracked deals
189
189 tracked deals across 2015-2026.
Tracked deals
189
189 tracked deals across 2015-2026.
Buyer mix
Strategic-led
174 strategic · 54 pe
Top trend
Volume peaked in 2026
37 tracked deals announced in 2026.
Primary Insight
Build a buyer list for your Healthcare Services deal
Find buyers actively acquiring healthcare services companies.
Find buyers like these for your dealBuyer Snapshot
Illustrative buyers pulled from tracked transactions on this page. This table is capped and intentionally non-exhaustive.
| Buyer | # Deals | Focus | Type |
|---|---|---|---|
| WELL Health Technologies Corp. | 10 | Publicly traded Canadian healthcare technology company th... | Strategic |
| Mednow Inc. | 6 | Canada-based virtual pharmacy and healthcare technology c... | Strategic |
| Peloton Capital Management | 6 | Toronto-based private equity firm focused on North Americ... | PE |
| Persistence Capital Partners | 5 | Healthcare-focused private equity firm and largest shareh... | PE |
| INTEGRAcare Inc. | 4 | Toronto-based private nursing and home healthcare provide... | Strategic |
| PharmaCorp Rx Inc. | 4 | Canadian pharmacy acquisition and ownership platform focu... | Strategic |
| Mable Health Inc. | 3 | Canadian healthcare platform that acquires and operates o... | Strategic (PE-backed) |
| SeaFort Capital | 3 | Halifax-based private equity firm investing in lower-mid-... | PE |
| 123Dentist | 2 | Dental support organization (DSO) scaling clinic networks... | Strategic |
| Arsenal Capital Partners | 2 | Middle-market private equity firm specializing in healthc... | PE |
Last 9 years
Supporting Data
SteriMax Inc. acquired Andone Pharmaceuticals Inc., a Canadian pharmaceutical and medical device company based in Oakville, Ontario. The deal strengthens SteriMax’s injectable business while expanding its platform into medical device and veterinary markets, with Andone founder Jay Barat joining SteriMax to lead those new businesses.
Merrithew International Inc. announced the acquisition of the GYROTONIC organization, creator of the GYROTONIC and GYROKINESIS movement methods. The deal is intended to strengthen Merrithew’s global leadership in mindful movement education, training, and equipment by expanding its education and programming portfolio.
PharmaEssentia Corporation announced it will acquire 100% of Canadian specialty pharmaceutical company FORUS Therapeutics Inc. in a transaction valued at US$36.5 million. The deal is intended to deepen PharmaEssentia’s presence in Canada’s hematology-oncology myeloproliferative neoplasm (MPN) market and accelerate commercialization of BESREMi (ropeginterferon alfa-2b) by integrating FORUS’s regulatory, medical, and commercial capabilities.
Red White & Bloom Brands, through its wholly owned subsidiary Emblem Cannabis Corporation, has completed the acquisition of Ayurcann in a court-supervised CCAA sale process. The deal adds the Fuego, Xplor and Happy & Stoned vape and pre-roll brands, a Health Canada-licensed formulation/manufacturing and packaging facility in Pickering, Ontario, and national distribution across eight provinces and territories.
PharmaCorp RX Inc. has entered into a definitive share purchase agreement to acquire a 100% interest in a PharmaChoice Canada bannered pharmacy located in Morrisburg, Ontario, from an arm's-length vendor group. The deal has an aggregate purchase price of approximately $8.2 million and is expected to close within about 60 days, subject to customary conditions including Ontario College of Pharmacists approval.
Canada Life has acquired Santé Circle Health, a provider of disability management and occupational health services. The acquisition is intended to strengthen and modernize Canada Life’s disability offering by combining Santé Circle Health’s early intervention, provider management and digital intake capabilities with Canada Life’s existing disability case management strengths.
Cannara Biotech Inc. has completed its acquisition of all shares of Medican Organic Inc. for an aggregate purchase price of CAD $2.8 million. The deal adds Medican’s cultivation, post-harvest, and extract manufacturing know-how, following Cannara’s earlier purchase of Medican’s Valleyfield cultivation and manufacturing facility in 2021.
Nova Leap Health Corp.’s Canadian subsidiary, Earth Angels Home Care, completed the acquisition of Parkwood Home Care Limited’s shares. The deal closed on May 1, 2026 for total consideration of CAD 3.5 million, with CAD 3.2 million paid in cash and CAD 0.3 million paid via a three-year promissory note.
Red Light Holland Corp. acquired Filament Health Corp. through a statutory plan of arrangement effective April 29, 2026. The deal creates a vertically integrated psychedelic platform spanning IND-enabled development, controlled-substance licensing/compliance, and global commercialization and distribution.
PharmaCorp Rx Inc. has entered into definitive share purchase agreements to acquire eight PharmaChoice Canada bannered pharmacies located in Eastern Canada for an aggregate purchase price of approximately $24.2 million. The deal is expected to increase PharmaCorp’s store count from six to fourteen locations and is expected to close within 60 days, subject to customary conditions.
Vigilance Santé, a Canadian provider of clinical decision support software and medication databases, has acquired MedSafer, a Quebec-based company that developed and validated deprescribing decision-support tools. The acquisition is intended to strengthen Vigilance Santé’s ability to help clinicians optimize medication use for older adults and expand its capacity in Canada.
Purkinje announced its acquisition of LeoMed Technologies, a virtual care platform focused on hospital-at-home services and other patient-at-home offerings. Purkinje said the deal will integrate LeoMed to accelerate deployment of digital solutions, streamline clinical workflows, and strengthen coordination and monitoring from hospital to home.
Westland Benefits, the employee benefits division of Westland Insurance Group, acquired Chilliwack, British Columbia–based Synchronized Employee Benefits Corporation effective April 16, 2026. The deal expands Westland Benefits’ national advisory capabilities and grows its footprint in the Fraser Valley while maintaining a client-centric, local-service approach.
Kindred Home Care Inc. acquired TLC Nursing Home Care Services Limited to expand its home care footprint into Newfoundland and Labrador. The transaction closed on April 1, 2026, and financial terms were not disclosed.
Emcure Pharmaceuticals’ step-down subsidiary, Mantra Pharma Inc. (Canada), acquired 100% of Cutimed Inc. for up to CAD 5.05 million. Immediately after the acquisition, Cutimed was amalgamated with Mantra effective April 1, 2026 to streamline operations and improve administrative efficiencies, strengthening Emcure’s Canadian cosmetic and dermatological product presence.
Extendicare completed the acquisition of CBI Home Health LP and CBI (GP) 3 Inc. and their subsidiaries for a cash purchase price of $570.0 million, plus approximately $13.6 million in estimated lease liabilities (IFRS 16). The deal was completed on April 1, 2026 through Extendicare’s wholly-owned subsidiary, ParaMed Inc., with funding from a private placement, draws under Extendicare’s credit facility, and cash on hand.
Blue Cross Life Insurance Company of Canada has agreed to acquire StanCorp Financial Group’s Canadian voluntary benefits business, including critical illness and accident insurance products, subject to regulatory approvals. The acquired portfolio currently covers about 170,000 employees and their families, and the transaction is expected to close later in 2026.
Idealist Capital led a C$50 million growth equity investment in sustainable agriculture company Solugen Global. The Canada Growth Fund also participated in the equity commitment as Solugen plans to scale production of its low-carbon, fast-release fertilizer Azogen.
WELL Health Technologies’ majority-owned subsidiary WELLSTAR completed the acquisition of two medical billing assets: PatientSERV in Ontario and Lambert Médico Factures in Québec. The deals expand WELLSTAR’s national medical billing platform, extending coverage to six Canadian provinces and strengthening its clinical operations offering for physicians.
Canopy Growth Corporation completed its previously announced arrangement to acquire all issued and outstanding common shares of MTL Cannabis Corp., making MTL a wholly owned subsidiary. The deal strengthens Canopy Growth’s Canadian medical cannabis platform and expands premium flower supply and operations to better serve regulated international medical markets, including Europe.
Crescita Therapeutics Inc. has entered into a definitive arrangement agreement to be acquired by ClinActiv Holdings Inc. in an all-cash transaction valued at $0.80 per share (minimum $0.75 per share), subject to working-capital adjustments. The transaction is expected to close in the second quarter of 2026 and will result in Crescita shares being delisted from the Toronto Stock Exchange, with a post-closing reorganization in which ClinActiv retains the commercial skincare and contract manufacturing business.
Hydreight Technologies Inc. closed a $300,000 strategic investment in Insu Therapeutics Inc. through the acquisition of 800,000 units at $0.375 per unit under a subscription agreement dated March 4, 2026. Each unit consists of one Insu common share and one warrant to purchase one Hydreight common share, with Hydreight also receiving exclusive U.S. distribution rights for peptide therapeutics using Insu’s buccal delivery technology, subject to regulatory approvals.
Equinoxe LifeCare, a Quebec-based private homecare provider, has acquired a majority stake in Ottawa-based Choice Homecare through a strategic alliance. The deal is intended to strengthen Equinoxe’s national footprint in Canada and expand homecare services in Ontario.
Spring Living Retirement Communities has acquired six retirement residences in Eastern Ontario, totaling 766 suites. The properties include Westwood Retirement Community in Ottawa plus five Ontario communities, expanding Spring Living’s senior living footprint to 29 properties and 3,500 suites across Ontario and Québec.
Octane Medical Group entered into a definitive agreement to acquire Lonza’s Personalized Medicine business, including Lonza’s controlling stake in the Cocoon cell-therapy platform plus related intellectual property, workforce, and existing customer contracts. The transaction is expected to close by the end of Q1 2026, subject to customary closing conditions.
BioSyent Inc. has successfully closed its previously announced acquisition of Oral Science Inc. for a total purchase price of $25.5 million. The deal was completed via a share purchase agreement dated February 8, 2026, with consideration paid through a mix of cash and BioSyent shares, and includes contingent earn-out and royalty payments.
Exact Imaging, a developer of high-resolution micro-ultrasound for urologic imaging, announced the closing of a $10 million financing round led by iGan Partners. The proceeds will be used to accelerate global sales and adoption of its ExactVu prostate biopsy system.
Apollo Global Management will acquire a minority stake in The GoodLife Group, Canada’s largest gym operator, with terms not disclosed. The investment is intended to provide capital to advance GoodLife’s long-term growth strategy while keeping founder David “Patch” Patchell-Evans and CEO Jeff van Haeren in place.
fdp Private Wealth Management announced the immediate acquisition of a majority interest in MultiD, a Quebec-based medical billing and administrative solutions firm. The deal is intended to create a fully integrated medical-finance offering for physicians across Quebec while maintaining MultiD’s brand and service continuity.
GreenShield has acquired Kii Health’s Canadian mental health services segment, including EFAP, Student Assistance Program (SAP), CBT Associates, and TAiCBT services, along with the MindBeacon digital therapy platform. The deal expands GreenShield Health’s mental health capabilities and grows its national footprint—particularly in Western Canada and Quebec—while integrating the acquired offerings into GreenShield+.
Corus Orthodontists Inc. announced a C$20 million institutional equity investment led by ATB Financial’s private equity arm, with co-investment from a prominent Canadian family office. The funding is intended to support further clinic expansion across the U.S. and Canada and to provide progressive equity liquidity to Corus’ existing shareholders.
WELL Health Technologies Corp. acquired a majority 61% ownership interest in E-Consult Canada LP for approximately CAD 33 million and completed the acquisition effective February 1, 2026. In addition, WELL acquired eight primary care clinics in Alberta (closing December 1, 2025), taking 100% ownership of the clinic business through its absorption model.
Elevate Farms Inc. acquired 100% of Fieldless Farms Inc., making Fieldless a wholly owned subsidiary of Elevate. The deal brings together Elevate’s controlled-environment agriculture (CEA) technology platform with Fieldless’s Cornwall, Ontario pesticide-free leafy greens operations, aiming to strengthen Canadian food sovereignty and enable global expansion.
Kiwa ASI, a food safety inspections, certifications, training and consulting provider based in St. Louis, announced that TSLC, a Canadian certification body specializing in CanadaGAP audits, has become part of Kiwa ASI. The deal expands Kiwa ASI’s footprint in Canada and strengthens its position in the agriculture sector of the food industry.
Victoria Park Medispa, a Canadian medical aesthetics platform, has acquired PHI Medical Aesthetics as its first entry into Alberta and the western provinces. The transaction is positioned as the start of Victoria Park’s broader westward expansion strategy, adding PHI’s Calgary injectables-focused clinic to its growing national network.
Funds affiliated with GTCR LLC acquired 100% of dentalcorp Holdings Ltd. through a statutory plan of arrangement, paying C$11.00 per share in cash. The transaction valued dentalcorp at approximately C$2.2 billion on an equity basis and C$3.3 billion on an enterprise value basis, and resulted in the company being taken private.
United BioSource LLC (UBC) acquired Evidinno Outcomes Research Inc., a Vancouver-based healthcare research consulting firm specializing in real-world evidence (RWE), epidemiology, evidence synthesis, and health economics/HEOR. The acquisition will expand UBC’s evidence generation and late-stage/post-approval capabilities, with Evidinno operating as a wholly owned subsidiary.
FluidAI Medical acquired Emmetros Limited, the developer of the SparxConnect patient engagement platform, to integrate its capabilities into FluidAI's Stream Inara offering. The deal strengthens FluidAI's RISE surgical recovery suite by expanding patient education, continuous engagement, and post-discharge monitoring to support earlier discharge and improved recovery outcomes.
GE HealthCare entered into an agreement to acquire Intelerad, a medical imaging software provider, for $2.3 billion in cash. The deal is intended to expand GE HealthCare’s cloud-first, AI-enabled enterprise imaging portfolio across outpatient/ambulatory, teleradiology, and hospital settings, while increasing recurring SaaS revenues.
UPS completed its acquisition of Andlauer Healthcare Group Inc. (AHG) for approximately CAD $2.2 billion (USD $1.6 billion). AHG shareholders received CAD $55.00 per share in cash, and the deal expands UPS Healthcare’s cold chain and complex healthcare logistics capabilities across North America and globally.
DoseMe, a portfolio company of Fairlong Capital, has acquired Firstline, a Vancouver-based clinical decision support platform. The acquisition combines Firstline's infectious disease guidance and antimicrobial stewardship capabilities with DoseMe's model-informed precision dosing software to create an end-to-end clinical decision support solution for hospitals and health systems.
Frontline Healthcare Partners, a private equity firm focused on distributed healthcare businesses, has acquired a controlling interest in Integracare Inc., a private-pay home care provider headquartered in Toronto, Ontario. Frontline will partner with Integracare’s president and CEO Lee Grunberg to grow the business organically and via a dedicated acquisition strategy across Ontario and beyond.
123Dentist entered into a definitive agreement to acquire MCA Dental Group Limited, an Ottawa-based dental support organization with 27 locations across Ontario and Québec. After completion, MCA Dental Group’s corporate brand will be retired and operations will transition to 123Dentist under a unified brand.
PharmaCorp Rx Inc. (TSXV: PCRX) completed the purchase of a 100% interest in an independent pharmacy located in Western Canada for CAD 2,400,000, funded with cash on hand. The deal is the company's fourth completed pharmacy acquisition and is being executed in conjunction with its strategic alliance with PharmaChoice Canada to grow PharmaCorp's network of bannered community pharmacies.
Doximity has acquired Montreal-based Pathway Medical Inc., a startup specializing in AI-powered clinical reference and decision support. The deal closed July 29, 2025 for $26 million in cash plus up to $37 million in equity grants (total consideration up to $63 million), bringing Pathway's physician-led AI team and datasets into Doximity's clinical product suite.
WELL Health Technologies Corp. completed two acquisitions of clinics in British Columbia on July 1, 2025 — a personalized/ longevity-focused clinic in Vancouver and a large primary care and specialty clinic in Burnaby. The acquisitions are expected to add over C$12 million in annual revenue and roughly C$3 million in Adjusted EBITDA, supporting WELL's continued expansion of its Canadian clinics platform.
VitalHub Corp. has acquired Novari Health Inc., a Kingston-based provider of patient flow and referral management software, for total up-front consideration of $43.6 million plus potential performance-based consideration (up to $5.0 million earnout). The acquisition strengthens VitalHub's patient-flow and referral management capabilities and is expected to accelerate Novari's international expansion leveraging VitalHub's footprint, particularly in the UK.
Theratechnologies entered into a definitive arrangement agreement to be acquired by CB Biotechnology, an affiliate of Future Pak, for US$3.01 per share in cash plus a contingent value right (CVR). The all-in consideration totals up to US$254 million assuming full CVR payment, with closing expected in the fourth quarter ending November 30, 2025 subject to approvals and customary conditions.
MDBriefCase, a Think Research subsidiary, has acquired Postcall, a fast-growing Canadian newsletter for physicians founded in 2023 by Eric Wu and Ziming Yang. The acquisition expands MDBriefCase's content offerings and audience reach across the medical community by adding Postcall's concise, weekly physician-focused newsletter.
Fullscript, a healthcare platform powering whole-person care, announced an expanded investment from private equity firms HGGC and Snapdragon Capital Partners, supported by a continuation vehicle led by Leonard Green & Partners as sole lead investor. The financing provides liquidity options to existing investors while supplying capital to support Fullscript's next phase of growth and further development of its provider-facing platform and fulfillment capabilities.
Full Export
Get the full acquisitions list for this page as CSV + XLSX.
Find buyers actively acquiring healthcare services companies.
The page includes care delivery (including home care), pharmacy banner acquisitions, disability management and occupational health services, and clinical decision support / virtual care technology.
Recent activity is shown across multiple provinces, including Ontario, Quebec, British Columbia, Nova Scotia, Saskatchewan, and New Brunswick, among others.
Yes. For example, Vigilance Santé acquired MedSafer, and Purkinje acquired LeoMed Technologies to strengthen digital solutions and clinical workflows.
Yes. The page includes both healthcare service providers (e.g., disability/occupational health and home care) and specialty pharmaceutical activity (e.g., PharmaEssentia acquiring FORUS Therapeutics).